INTERPACE BIOSCIENCES, INC. Contingent Consideration Classified as Equity, Fair Value Disclosure
INTERPACE BIOSCIENCES, INC. (IDXGD) had Contingent Consideration Classified as Equity, Fair Value Disclosure of $1.82 million as of 2014-12-31, per its 10-K filed 2016-03-30.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure · last filed 2016-03-30
- 2014-12-31: Contingent Consideration Classified as Equity, Fair Value Disclosure $1.82M.
| Period end | Contingent Consideration Classified as Equity, Fair Value Disclosure |
|---|---|
| 2014-12-31 | $1.82M 10-K · filed 2016-03-30 |